Biofrontera Inc. Common Stock (BFRI) is a publicly traded Healthcare sector company. As of May 21, 2026, BFRI trades at $0.81 with a market cap of $9.54M and a P/E ratio of -0.77. BFRI moved +0.51% today. Year to date, BFRI is +1.23%; over the trailing twelve months it is +22.43%. Its 52-week range spans $0.54 to $2.22. Analyst consensus is buy with an average price target of $9.00. Rallies surfaces BFRI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Hedge funds tracked by Rallies that own BFRI include Two Sigma and Renaissance Technologies. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Biofrontera Inc. Common Stock.
| Metric | Value |
|---|---|
| Price | $0.81 |
| Market Cap | $9.54M |
| P/E Ratio | -0.77 |
| EPS | $-1.04 |
| Dividend Yield | 0.00% |
| 52-Week High | $2.22 |
| 52-Week Low | $0.54 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $41.70M |
| Net Income | $-10.54M |
| Gross Margin | 0.00% |
1 analysts cover BFRI: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $9.00.